HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +21.4% ·
flujo de acciones +24.3% ·
nuevas posiciones netas +17.6%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 132 | -2 | 91.18M | $6.60B | +5 | −6 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | — | — |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | — | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | — | −1 |
| Q2 2024 | 14 | — | 8.14M | $426.06M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 7.18M | — | $343.50M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasivo) | 7.18M | — | $343.50M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 3.06M | +0.1% | $146.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 3.06M | +0.1% | $146.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.26M | Nuevo | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.26M | Nuevo | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.26M | Nuevo | $60.37M | 0.1% | New | 1 | SEC ↗ |
| 8 | Norges Bank ✦ (pasivo) | 1.26M | +15.2% | $60.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 1.22M | -4.1% | $58.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 1.22M | -4.1% | $58.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 992.89K | +141.3% | $47.47M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 831.41K | +171.2% | $39.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 831.41K | +171.2% | $39.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Capital World Investors ✦ | 748.23K | Nuevo | $35.77M | 0.0% | New | 1 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 414.72K | +28.0% | $19.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 247.03K | +403.0% | $11.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Millennium Management ✦ | 95.42K | +254.5% | $4.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Millennium Management ✦ | 95.42K | +254.5% | $4.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 84.83K | Nuevo | $4.06M | 0.0% | New | 1 | SEC ↗ |
| 20 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 57.37K | -11.9% | $2.74M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 52.96K | +0.8% | $2.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 47.44K | +9.7% | $2.27M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 26.11K | -89.8% | $1.25M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Marshall Wace ✦ | 4.43K | Nuevo | $211,607 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $60.37M | 0.1% |
| Citadel Advisors | $60.37M | 0.1% |
| Citadel Advisors | $60.37M | 0.1% |
| Capital World Investors | $35.77M | 0.0% |
| Point72 Asset Management | $4.06M | 0.0% |
| Marshall Wace | $211,607 | 0.0% |
Posición cerrada
| Bridgewater Associates | $659,119 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 8 tenedores, 32.79M acciones, $43.93M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 9.60K acc. · $1.03M
Officer, Director · 3.20K acc. · $344,848
Officer, Director · 7.20K acc. · $765,778
Officer, Director · 5.70K acc. · $587,882
Officer, Director · 9.40K acc. · $985,816
Officer, Director · 4.90K acc. · $509,827
Officer, Director · 900 acc. · $89,062
Officer, Director · 500 acc. · $50,228
Officer, Director · 2.10K acc. · $213,709
Officer, Director · 9.00K acc. · $922,977
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología